nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis
|
Tsuchiya, Takahiro |
|
|
41 |
2 |
p. 73-79 |
artikel |
2 |
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next
|
Komori, Takashi |
|
|
41 |
2 |
p. 96 |
artikel |
3 |
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas
|
Nakashima, Takuma |
|
|
41 |
2 |
p. 50-60 |
artikel |
4 |
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma
|
Masui, Kenta |
|
|
41 |
2 |
p. 92-95 |
artikel |
5 |
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy
|
Sasaki, Hikaru |
|
|
41 |
2 |
p. 43-49 |
artikel |
6 |
Preface for Brain Tumor Pathology vol.41 issue 2
|
Nagane, Motoo |
|
|
41 |
2 |
p. 41-42 |
artikel |
7 |
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature
|
Natsumeda, Manabu |
|
|
41 |
2 |
p. 85-91 |
artikel |
8 |
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment
|
Higuchi, Fumi |
|
|
41 |
2 |
p. 80-84 |
artikel |
9 |
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment
|
Ezaki, Taketo |
|
|
41 |
2 |
p. 61-72 |
artikel |